The methyl-CpG binding protein MBD1 is required for PML-RARα function

被引:79
作者
Villa, R
Morey, L
Raker, VA
Buschbeck, M
Gutierrez, A
De Santis, F
Corsaro, M
Varas, F
Bossi, D
Minucci, S
Pelicci, PG
Di Croce, L
机构
[1] Univ Pompeu Fabra, Ctr Regulac Gen, Barcelona 08003, Spain
[2] European Inst Oncol, I-20141 Milan, Italy
[3] Inst Catalana Rec & Estudis Avancats, Barcelona 08003, Spain
[4] Ctr Regulac Gen, Barcelona 08003, Spain
关键词
chromatin; epigenetics; leukemia;
D O I
10.1073/pnas.0509343103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PML-RAR alpha induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This block is based on its capacity to inactivate target genes by recruiting histone deacetylase (HDAC) and DNA methyltransferase activities. Here we report that MBD1, a member of a conserved family of proteins able to bind methylated DNA, cooperates with PML-RAR alpha in transcriptional repression and cellular transformation. PML-RAR alpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Binding of HDAC3 and MBD1 is not confined to the promoter region but instead is spread over the locus. Knock-down of HDAC3 expression by RNA interference in acute promyelocytic leukemia cells alleviates PML-RAR-induced promoter silencing. We further demonstrate that retroviral expression of dominant-negative mutants of MBD1 in hematopoietic precursors compromises the ability of PML-RAR alpha to block their differentiation and thus restored cell differentiation. Our results demonstrate that PML-RAR alpha functions by recruiting an HDAC3-MBD1 complex that contributes to the establishment and maintenance of the silenced chromatin state.
引用
收藏
页码:1400 / 1405
页数:6
相关论文
共 40 条
[1]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[2]   Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice [J].
Chen, RZ ;
Akbarian, S ;
Tudor, M ;
Jaenisch, R .
NATURE GENETICS, 2001, 27 (03) :327-331
[3]   Chromatin modifying activity of leukaemia associated fusion proteins [J].
Di Croce, L .
HUMAN MOLECULAR GENETICS, 2005, 14 :R77-R84
[4]   Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor [J].
Di Croce, L ;
Raker, VA ;
Corsaro, M ;
Fazi, F ;
Fanelli, M ;
Faretta, M ;
Fuks, F ;
Lo Coco, F ;
Kouzarides, T ;
Nervi, C ;
Minucci, S ;
Pelicci, PG .
SCIENCE, 2002, 295 (5557) :1079-1082
[5]   Steroid and nuclear receptors Villefranche‐sur‐Mer, France, May 25–27, 1999 [J].
Luciano Di Croce ;
Sam Okret ;
Sander Kersten ;
Jan‐Åke Gustafsson ;
Malcolm Parker ;
Walter Wahli ;
Miguel Beato .
The EMBO Journal, 1999, 18 (22) :6201-6210
[6]   A kinetic framework for a mammalian RNA polymerase in vivo [J].
Dundr, M ;
Hoffmann-Rohrer, U ;
Hu, QY ;
Grummt, I ;
Rothblum, LI ;
Phair, RD ;
Misteli, T .
SCIENCE, 2002, 298 (5598) :1623-1626
[7]   Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg [J].
Esteller, M .
CLINICAL IMMUNOLOGY, 2003, 109 (01) :80-88
[8]   The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation [J].
Fajas, L ;
Egler, V ;
Reiter, R ;
Hansen, J ;
Kristiansen, K ;
Debril, MB ;
Miard, S ;
Auwerx, J .
DEVELOPMENTAL CELL, 2002, 3 (06) :903-910
[9]   Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo [J].
Fazi, F ;
Travaglini, L ;
Carotti, D ;
Palitti, F ;
Diverio, D ;
Alcalay, M ;
McNamara, S ;
Miller, WH ;
Lo Coco, F ;
Pelicci, PG ;
Nervi, C .
ONCOGENE, 2005, 24 (11) :1820-1830
[10]   Enzymatic activity associated with class IIHDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR [J].
Fischle, W ;
Dequiedt, F ;
Hendzel, MJ ;
Guenther, MG ;
Lazar, MA ;
Voelter, W ;
Verdin, E .
MOLECULAR CELL, 2002, 9 (01) :45-57